[Form 4] Conifer Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Clarkston 91 West LLC reported the disposition of certain securities of Presurance Holdings, Inc. (PRHI) on 10/08/2025. The filing shows a sale/disposition of 1,500 Series B preferred shares (reported price $5,000) leaving 0 Series B shares beneficially owned. The filing also reports a disposition of 4,000,000 warrants to purchase common stock (exercise price $1.50, expiration 01/31/2027) with 0 underlying common shares retained. The reporting person is listed as a Director and 10% owner; the form is signed by Jeffrey Hakala.

Positive

• Timely disclosure of insider transactions by a Director and 10% owner on 10/08/2025
• Complete reduction to zero of reported Series B preferred and warrant holdings, clarifying current insider exposure

Negative

• Large warrant disposition of 4,000,000 warrants could reduce insider-aligned upside in common stock
• Series B preferred sold (1,500 shares at $5,000 reported) removing that preferred-class stake

Insights

Corporate Insider Filings Analyst

TL;DR: Director and 10% owner disposed of preferred shares and warrants, reducing disclosed holdings to zero for those instruments.

The filing records a disposition on 10/08/2025 of 1,500 Series B preferred shares and 4,000,000 warrants to purchase common stock, with the warrants carrying a $1.50 exercise price and expiring on 01/31/2027. The report lists the holder as a Director and 10% owner, and shows 0 remaining beneficial ownership in those classes after the transactions.

Primary dependencies are the accuracy of the reported price and the separate status of other holdings not listed. Monitor public filings for any related Form 5 or amendments within the usual reporting window to confirm whether these dispositions reflect a permanent exit from those instruments or part of a broader transaction completed around 10/08/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Clarkston 91 West LLC

(Last) (First) (Middle)

303 E THIRD STREET

SUITE 110

(Street)

ROCHESTER MI 48307

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Presurance Holdings, Inc. [ PRHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Series B Preferred Stock	10/08/2025		D		1,500	D	$5,000	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant to Purchase Common Stock	$1.5	10/08/2025		D			4,000,000	06/03/2025	01/31/2027	Common Stock	4,000,000	$0	0	D

Explanation of Responses:

	/s/ Jeffrey Hakala, Member	10/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for PRHI (Presurance Holdings) disclose on 10/08/2025?

It disclosed dispositions of 1,500 Series B preferred shares and 4,000,000 warrants to purchase common stock on 10/08/2025, leaving 0 beneficial ownership in those instruments.

Who filed the Form 4 for PRHI and what is their relationship to the company?

The reporting person is Clarkston 91 West LLC, listed as a Director and 10% owner, with the form signed by Jeffrey Hakala.

What are the terms of the warrants disposed of in the filing?

The warrants had an $1.50 exercise price, underlying 4,000,000 common shares, and an expiration date of 01/31/2027.

Did the filer retain any of the Series B preferred or warrants after the reported transactions?

No; the Form 4 shows 0 beneficially owned Series B preferred shares and 0 underlying common shares from the warrants following the dispositions.